CAWACHI LIMITED
2664株式会社カワチ薬品
Latest half-year results
First half · fiscal year to 2027-03 · filed 2026-10-29For the first half of the fiscal year to 2027-03: Revenue ¥144.1 billion (-0.8% YoY), Ordinary income ¥3.5 billion (-8.9% YoY), Net income ¥2.2 billion (-8.6% YoY).
| This period | Year on year | |
|---|---|---|
| Revenue | ¥144.1bn | -0.8% |
| Ordinary profit | ¥3.5bn | -8.9% |
| Net profit to owners | ¥2.2bn | -8.6% |
From the securities report on EDINET, which states no forecast. History via /v1/companies/2664/earnings-releases.
Financials
Japan GAAP · consolidated · fiscal year to 2026-03-15- Revenue
- ¥284.5bn
- Net income
- ¥3.2bn
- ROE
- 2.8%
- Equity ratio
- 58.0%
- Dividend / share
- ¥100
- Employees
- 2,750
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2026-03-15 | ¥284.5bn | ¥3.2bn | ¥199.6bn | ¥115.9bn | 2.8% | ¥143.3 | ¥8.9bn |
| 2025-03-15 | ¥287.8bn | ¥4.9bn | ¥199.6bn | ¥114.4bn | 4.3% | ¥218.72 | ¥7.5bn |
| 2024-03-15 | ¥286.0bn | ¥4.7bn | ¥196.1bn | ¥111.3bn | 4.3% | ¥211.03 | ¥6.4bn |
| 2023-03-15 | ¥281.9bn | ¥4.2bn | ¥194.5bn | ¥107.7bn | 3.9% | ¥187.06 | ¥9.8bn |
| 2022-03-15 | ¥279.5bn | ¥4.8bn | ¥191.7bn | ¥104.6bn | 4.7% | ¥216.44 | ¥6.9bn |
Indicators
Computed by us from filings · fiscal year to 2026-03-15| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | 2.8 | 14.1 |
| Ordinary margin | 0.0278 | 22.3 |
| Equity ratio, % | 58 | 54.4 |
| Revenue growth | -0.0115 | 20.9 |
| Net income growth | -0.3448 | 16.9 |
| Operating cash flow / assets | 0.0444 | 36.6 |
Results wording balance: +0.33. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥16.1bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥81m, 0.9% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/2664/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states them/v1/companies/2664/buybacksSegments, votes and tender offers
Stated in EDINET filings/v1/companies/2664/votingOwnership changes
All companies →- 2026-06-10
Kaname Capital, L.P. states it may make proposals to the management of CAWACHI LIMITED (2664) (first filing).
- 2026-06-10
Kaname Capital, L.P. disclosed a 5.01% stake in CAWACHI LIMITED (2664), crossing the 5% reporting threshold.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| Kaname Capital,L.P. | 2026-04-07 – 2026-06-04 | +625,300 | +2.53pt | — | — |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/2664/trades.
5% filings
Large shareholding reports on 2664| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-06-10 | Kaname Capital, L.P. | 5.01% | — | control may make proposals undervaluation thesis |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- 2 issues
- Book value
- ¥294m
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 1
- Held by listed cos.
- 12
| Holds | Book value | Shares vs. prior year | Mutual |
|---|---|---|---|
| Mebuki Financial Group,Inc. 7167 | ¥190m | 0.0% | no |
| THE TOCHIGI BANK, LTD. 8550 | ¥104m | 0.0% | both reports |
Held by: THE TOCHIGI BANK, LTD. 8550, UNICHARM CORPORATION 8113, TOTETSU KOGYO CO.,LTD. 1835, 8283 8283, ARATA CORPORATION 2733, Daio Paper Corporation 3880, KOBAYASHI PHARMACEUTICAL CO.,LTD. 4967, Alfresa Holdings Corporation 2784, CREATE SD HOLDINGS CO.,LTD 3148, KANSEKI CO.,LTD. 9903, MatsukiyoCocokara & Co 3088, COSMOS Pharmaceutical Corporation 3349
Purposes, all holdings and mutual flags via /v1/companies/2664/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2026-03-15| Shareholder | Shares | Ratio |
|---|---|---|
| 公益財団法人河内奨学財団 | 2,600,000 | 11.64% |
| individual holder | 2,438,000 | 10.92% |
| individual holder | 2,287,000 | 10.24% |
| 日本マスタートラスト信託銀行株式会社（信託口） | 1,571,000 | 7.04% |
| individual holder | 1,330,000 | 5.96% |
| individual holder | 708,000 | 3.17% |
| カワチ薬品従業員持株会 | 326,000 | 1.46% |
| 株式会社日本カストディ銀行（信託口） | 300,000 | 1.35% |
| PERSHING－DIV.OF DLJ SECS.CORP. | 283,000 | 1.27% |
| JAPAN ABSOLUTE VALUE FUND | 247,000 | 1.11% |
U.S. funds holding 2664
SEC Form N-PORT, reports to 2026-07-3139 U.S. funds held 1,217,191 shares worth $25.4m.
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| DFA INTERNATIONAL SMALL CAP VALUE PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 292,400 | $6.1m | 0.043% | 2026-07-31 |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 165,562 | $3.5m | 0.001% | 2026-07-31 |
| VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS | 121,031 | $2.6m | 0.001% | 2026-06-30 |
| Avantis International Small Cap Value ETF American Century ETF Trust | 101,000 | $2.1m | 0.010% | 2026-05-31 |
| Dimensional International Small Cap Value ETF Dimensional ETF Trust | 92,200 | $1.9m | 0.039% | 2026-07-31 |
Up to 25 funds per stock via the API.
Get this as JSON
GET /v1/companies/2664
GET /v1/companies/2664/financials
GET /v1/companies/2664/details
GET /v1/companies/2664/segments
GET /v1/companies/2664/voting
GET /v1/companies/2664/tender-offers
GET /v1/companies/2664/indicators
GET /v1/companies/2664/earnings-releases
GET /v1/events?ticker=2664
GET /v1/companies/2664/trades
GET /v1/companies/2664/cross-holdings
GET /v1/companies/2664/brief